Cytena Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 74

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $33.8M

Cytena General Information

Description

Developer of a single-cell printing technology designed to assist contact-free deposition of single cells encapsulated in micro-droplets. The company's technology is based on an inkjet-like print head with integrated imaging sensors, providing efficient and fast single-cell seeding combined with good cell viability and zero risk of cross-contamination, enabling clients to deliver enhanced and efficient medication to their patients thereby improving their outcomes.

Contact Information

Website
www.cytena.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Corporate Office
  • Zollhallenstr. 5
  • 79106 Freiburg
  • Germany
+49 0761 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytena Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 05-Aug-2019 $33.8M 00.00 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 26-Mar-2019 00.00 00.00 000.00 Completed Generating Revenue
4. Grant 29-Nov-2017 000.00 00.00 Completed Startup
3. Seed Round 08-May-2015 00.00 00.00 00.000 Completed Startup
2. Accelerator/Incubator 15-Jul-2014 $6.81K Completed Startup
1. Spin-Off 01-Jun-2014 Completed Startup
To view Cytena’s complete valuation and funding history, request access »

Cytena Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a single-cell printing technology designed to assist contact-free deposition of single cells encapsulated i
Biotechnology
Freiburg, Germany
74 As of 2023
00.00
00.00 0000-00-00
000000&0 00.00

000000

iam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo con
0000000000000
Lebanon, NH
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

000000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000000000000
South San Francisco, CA
00 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cytena Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avitide Formerly VC-backed Lebanon, NH 00 000.00 000000&0 000.00
Quantapore Venture Capital-Backed South San Francisco, CA 00 000.00 000000 - 000 000.00
AbCellera Formerly VC-backed Vancouver, Canada 000 00000 00000000 00000
Menarini Silicon Biosystems Formerly VC-backed Castel Maggiore, Italy 00000 000.00 000000&0 000.00
NanoCellect Biomedical Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 28 competitors. Get the full list »

Cytena Patents

Cytena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102023112687-A1 Device with dispenser for dispensing a liquid sample Pending 21-May-2022 000000000000 0
US-20230398538-A1 Device with a dispenser for dispensing a liquid sample Pending 21-May-2022 000000000000
DE-102022132894-A1 Method for determining a lower interface and/or an upper interface of a liquid in a container Pending 27-Dec-2021 00000000000 0
US-20230204403-A1 Method for determining a lower boundary surface and/or an upper boundary surface of a liquid located in a container Pending 27-Dec-2021 00000000000
JP-2023089964-A Microscope Pending 16-Dec-2021 G02B21/248
To view Cytena’s complete patent history, request access »

Cytena Executive Team (8)

Name Title Board Seat Contact Info
Julian Riba Ph.D Chief Executive Officer
Martin Knape Chief Operating Officer
Andre Gross Chief Technology Officer
Fabian Stumpf Ph.D Chief Marketing Officer
Andreas Hassellöf Chief Financial Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Cytena Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytena Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Germany's Federal Ministry of Economics and Technology Government 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
Science4Life Accelerator/Incubator 000 0000 000000 0
To view Cytena’s complete investors history, request access »

Cytena Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cytena Bioprocess Solutions 01-Aug-2021 00000 0000 000 Discovery Tools (Healthcare)
Cytena Bioprocess Solutions 01-Aug-2019 Corporate Discovery Tools (Healthcare)
To view Cytena’s complete investments history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »